Literature DB >> 23856509

MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis.

Georgios Koukos1, Christos Polytarchou, Jess L Kaplan, Alessio Morley-Fletcher, Beatriz Gras-Miralles, Efi Kokkotou, Mariah Baril-Dore, Charalabos Pothoulakis, Harland S Winter, Dimitrios Iliopoulos.   

Abstract

BACKGROUND & AIMS: Altered levels and functions of microRNAs (miRs) have been associated with inflammatory bowel diseases (IBDs), although little is known about their roles in pediatric IBD. We investigated whether colonic mucosal miRs are altered in children with ulcerative colitis (UC).
METHODS: We used a library of 316 miRs to identify those that regulate phosphorylation of signal transducer and activator of transcription 3 (STAT3) in NCM460 human colonocytes incubated with interleukin-6. Levels of miR-124 were measured by real-time polymerase chain reaction analysis of colon biopsies from pediatric and adult patients with UC and patients without IBD (controls), and of HCT-116 colonocytes incubated with 5-aza-2'-deoxycytidine (5-AZA). Methylation of the MIR124 promoter was measured by quantitative methylation-specific polymerase chain reaction.
RESULTS: Levels of phosphorylated STAT3 and the genes it regulates (encoding vascular endothelial growth factor (VEGF), BCL2, BCLXL, and matrix metallopeptidase 9 [MMP9]) were increased in pediatric patients with UC compared with control tissues. Overexpression of miR-124, let-7, miR-125, miR-26, or miR-101 reduced STAT3 phosphorylation by ≥ 75% in NCM460 cells; miR-124 had the greatest effect. miR-124 was down-regulated specifically in colon tissues from pediatric patients with UC and directly targeted STAT3 messenger RNA (mRNA). Levels of miR-124 were decreased, whereas levels of STAT3 phosphorylation increased in colon tissues from pediatric patients with active UC compared with those with inactive disease. In addition, levels of miR-124 and STAT3 were inversely correlated in mice with experimental colitis. Down-regulation of miR-124 in tissues from children with UC was attributed to hypermethylation of its promoter region. Incubation of HCT-116 colonocytes with 5-AZA up-regulated miR-124 and reduced levels of STAT3 mRNA.
CONCLUSIONS: miR-124 appears to regulate the expression of STAT3. Reduced levels of miR-124 in colon tissues of children with active UC appear to increase expression and activity of STAT3, which could promote inflammation and the pathogenesis of UC in children.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5-AZA; 5-aza-2′-deoxycytidine; BCLXL; CD; Crohn's disease; DSS; ELISA; Gene Regulation; IBD; IL; IL6; KO; Let-7; MMP9; PCR; STAT3; Tyr705; UC; VEGF; dextran sulfate sodium salt; enzyme-linked immunosorbent assay; inflammatory bowel disease; interleukin; knockout; mRNA; matrix metallopeptidase 9; messenger RNA; miR; microRNA; p-STAT3; phosphorylated STAT3; polymerase chain reaction; signal transducer and activator of transcription 3; tyrosine 705; ulcerative colitis; vascular endothelial growth factor

Mesh:

Substances:

Year:  2013        PMID: 23856509      PMCID: PMC4427058          DOI: 10.1053/j.gastro.2013.07.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

1.  Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease.

Authors:  Z Lin; J P Hegarty; J A Cappel; W Yu; X Chen; P Faber; Y Wang; A A Kelly; L S Poritz; B Z Peterson; S Schreiber; J-B Fan; W A Koltun
Journal:  Clin Genet       Date:  2010-10-18       Impact factor: 4.438

2.  Rapid development of colitis in NSAID-treated IL-10-deficient mice.

Authors:  Daniel J Berg; Juan Zhang; Joel V Weinstock; Hanan F Ismail; Keith A Earle; Hector Alila; Rifat Pamukcu; Steven Moore; Richard G Lynch
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

3.  Identification of disease-associated DNA methylation in B cells from Crohn's disease and ulcerative colitis patients.

Authors:  Zhenwu Lin; John P Hegarty; Wei Yu; Jon A Cappel; Xi Chen; Pieter W Faber; Yunhua Wang; Lisa S Poritz; Jian-Bing Fan; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2012-07-21       Impact factor: 3.199

4.  Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.

Authors:  Elias Stagakis; George Bertsias; Panayotis Verginis; Magdalene Nakou; Maria Hatziapostolou; Heraklis Kritikos; Dimitrios Iliopoulos; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2011-05-20       Impact factor: 19.103

5.  MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2.

Authors:  Juan Lu; Ming-Liang He; Lu Wang; Ying Chen; Xiong Liu; Qi Dong; Yang-Chao Chen; Ying Peng; Kai-Tai Yao; Hsiang-Fu Kung; Xiang-Ping Li
Journal:  Cancer Res       Date:  2011-01-01       Impact factor: 12.701

6.  Challenges in pediatric inflammatory bowel disease.

Authors:  Athos Bousvaros; Francisco Sylvester; Subra Kugathasan; Eva Szigethy; Claudio Fiocchi; Richard Colletti; Anthony Otley; Devendra Amre; George Ferry; Steven J Czinn; Judy B Splawski; Maria Oliva-Hemker; Jeffrey S Hyams; William A Faubion; Barbara S Kirschner; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2006-09       Impact factor: 5.325

7.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

Review 8.  Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.

Authors:  Raja Atreya; Markus F Neurath
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

9.  MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin.

Authors:  Jinqiang Zhang; Chang Han; Tong Wu
Journal:  Gastroenterology       Date:  2012-04-03       Impact factor: 22.682

10.  The Role of MicroRNA in Inflammatory Bowel Disease.

Authors:  Sushila R Dalal; John H Kwon
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-11
View more
  94 in total

1.  miR-101a and miR-30b contribute to inflammatory cytokine-mediated β-cell dysfunction.

Authors:  Ying Zheng; Zhen Wang; Yiting Tu; Hongwei Shen; Zhijie Dai; Jian Lin; Zhiguang Zhou
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

Review 2.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

3.  Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer.

Authors:  Xiuyuan Chen; Rui Mao; Wenmei Su; Xia Yang; Qianqian Geng; Chunfang Guo; Zhuwen Wang; Jun Wang; Laura A Kresty; David G Beer; Andrew C Chang; Guoan Chen
Journal:  Autophagy       Date:  2019-06-28       Impact factor: 16.016

Review 4.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

5.  MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1.

Authors:  Xin Dai; Xi Chen; Qun Chen; Lei Shi; Hongwei Liang; Zhen Zhou; Qian Liu; Wenjing Pang; Dongxia Hou; Cheng Wang; Ke Zen; Yaozong Yuan; Chen-Yu Zhang; Lu Xia
Journal:  J Biol Chem       Date:  2015-04-30       Impact factor: 5.157

6.  Polymorphisms in MIR122, MIR196A2, and MIR124A Genes are Associated with Clinical Phenotypes in Inflammatory Bowel Diseases.

Authors:  Cinzia Ciccacci; Cristina Politi; Livia Biancone; Andrea Latini; Giuseppe Novelli; Emma Calabrese; Paola Borgiani
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

7.  A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.

Authors:  David Padua; Swapna Mahurkar-Joshi; Ivy Ka Man Law; Christos Polytarchou; John P Vu; Joseph R Pisegna; David Shih; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-04       Impact factor: 4.052

Review 8.  Leukocyte-epithelial interactions and mucosal homeostasis.

Authors:  Jason D Matthews; Caroline M Weight; Charles A Parkos
Journal:  Toxicol Pathol       Date:  2013-11-27       Impact factor: 1.902

Review 9.  Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics.

Authors:  Eleni Stylianou
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

10.  Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt.

Authors:  Manasvi S Shah; Eunjoo Kim; Laurie A Davidson; Jason M Knight; Roger S Zoh; Jennifer S Goldsby; Evelyn S Callaway; Beyian Zhou; Ivan Ivanov; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.